Dr. Ching-Huei Tsou is a Research Manager and Senior Research Scientist at the IBM Thomas J. Watson Research Center, where he leads the Biomedical NLP team in the Healthcare and Life Sciences department. Before joining IBM, he worked at the MIT Auto-ID Lab and in industry, applying machine learning to large-scale sensor data and designing enterprise software systems, experience that positioned him to bridge fundamental innovation with real-world applications.At IBM, Dr. Tsou began on the Jeopardy-winning Watson team, helping translate state-of-the-art natural language processing into healthcare solutions. Over the past decade, he has advanced AI for medicine through research spanning clinical NLP, biomedical representation learning, and multimodal foundation models. His work has improved the usability of electronic health records, supported global public health efforts during the COVID-19 pandemic, and produced open biomedical foundation models such as BMFM-RNA, BMFM-DNA, and the BioVERSE framework.Beyond research, Dr. Tsou has been an active leader in the AI community, mentoring students, shaping benchmarking standards, and fostering collaboration across academia, industry, and healthcare. He is committed to open, reproducible science and envisions biomedical AI as a cornerstone of precision medicine, bridging molecular and clinical insights to accelerate discovery, improve patient care, and deliver lasting benefits to society.
AWARDS:
